VICTORIA, BC, Nov. 15, 2016 /CNW/ - Emerald Health Therapeutics Inc. (TSXV: EMH) ("Therapeutics") is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity of its stock.
The Company announces that it is not aware of any material, undisclosed corporate developments and has no material change to report at this time. The Company will keep the market informed as required.
ON BEHALF OF THE BOARD
"Dr. Avtar Dhillon"
Emerald Health Therapeutics Inc.
Therapeutics wholly owns Emerald Health Botanicals, Inc., which has been granted licences under the Access to Cannabis for Medical Purposes Regulations (Canada) to cultivate and sell medical cannabis, and to produce and sell medical cannabis oils in Canada.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Emerald Health Therapeutics, Inc.
For further information: Please contact Emerald Health Therapeutics CFO, Sandy Pratt, at 250-818-9838 or [email protected]